M 66 (Meloxicam 7.5 mg)

Pill with imprint M 66 is Yellow, Round and has been identified as Meloxicam 7.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Meloxicam is used in the treatment of osteoarthritis; juvenile rheumatoid arthritis; rheumatoid arthritis; pain and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 66

Meloxicam

Imprint:

M 66

Strength:

7.5 mg

Color:

Yellow

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Nonsteroidal anti-inflammatory drugs

Pregnancy Category:

C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Mylan Pharmaceuticals Inc.

Inactive Ingredients:

• silicon dioxide
• lactose monohydrate
• magnesium stearate
• microcrystalline cellulose
• sodium lauryl sulfate

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00378-1066	Mylan Pharmaceuticals Inc.
51079-0457	UDL Laboratories Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer